Clearance Summary
FRESENIUS DIALYSATE ACID CONCENTRATE received FDA 510(k) clearance under submission number K922088, sponsored by Fresenius USA, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 1994-10-17.
- Submission: K922088
- Applicant / Sponsor: Fresenius USA, Inc.
- Clearance pathway: Traditional
- Review panel: Gastroenterology, Urology
- Device class: Class II
- Regulation citation: 21 CFR 876.5820
- Decision date: 1994-10-17
Classification & Regulation
This clearance is catalogued under FDA product code KPO and 21 CFR 876.5820, within the Gastroenterology, Urology review panel as a Class II device.